Results 91 to 100 of about 20,430,225 (174)

Activity of Tivozanib in Non-clear Cell Renal Cell Carcinoma: Subgroup Analysis From a Phase II Randomized Discontinuation Trial. [PDF]

Oncologist, 2023
Barata PC, Chehrazi-Raffle A, Allman KD, Asnis-Alibozek A, Kasturi V, Pal SK.   +5 more
europepmc   +1 more source

Clinical outcomes of metastatic non-clear cell renal cell carcinoma: a real-world single-centre experience. [PDF]

Ann Med
Wu J, Cao CZ, Cui HL, Chen MX, Gao LN, Zheng S, Zhou AP, Guan YY, Bi XG, Shi HZ, Shou JZ.   +10 more
europepmc   +1 more source

Current Evidences and Future Perspectives in the Management of Metastatic Non-Clear Cell Renal Cell Carcinoma. [PDF]

Int J Urol
Nakanishi S, Inokuchi J.
europepmc   +1 more source

A Systematic Review of Immune Checkpoint Inhibitors in Non-Clear-Cell Renal Cancer. [PDF]

Kidney Cancer, 2022
Palma Dos Reis AF, Simão D, Odeny T, Rodrigues C, Fontes-Sousa M, da Luz R, Chowdry RP, Welsh SJ, Paller C, Barata PC.   +9 more
europepmc   +1 more source

Systemic Treatment for Advanced and Metastatic Non-Clear Cell Renal Cell Carcinoma: Examining Modern Therapeutic Strategies for a Notoriously Challenging Malignancy. [PDF]

J Kidney Cancer VHL, 2023
Drobner J, Portal D, Runcie K, Yang Y, Singer EA.   +4 more
europepmc   +1 more source

First-line PD-1 blockades combined with TKIs for metastatic non-clear cell renal cell carcinoma: a real-world multicenter retrospective study. [PDF]

Cancer Immunol Immunother
Zhong X, Huang T, Peng Y, Jing T, Ng C, Liu X, Wei W, Zhang Z, Han H, Chen M, Huang J, Dong P.   +11 more
europepmc   +1 more source

The efficacy of molecular targeted therapy and nivolumab therapy for metastatic non-clear cell renal cell carcinoma: A retrospective analysis using the Michinoku Japan urological cancer study group database. [PDF]

Cancer Med, 2023
Koguchi T, Naito S, Hatakeyama S, Numakura K, Muto Y, Kato R, Kojima T, Kawasaki Y, Morozumi K, Kandori S, Kawamura S, Nishiyama H, Ito A, Habuchi T, Obara W, Ohyama C, Tsuchiya N, Kojima Y.   +17 more
europepmc   +1 more source

Start of a New Era: Management of Non-Clear Cell Renal Cell Carcinoma in 2022. [PDF]

Curr Oncol Rep, 2022
Maughan BL.
europepmc   +1 more source

Systemic Treatment of Locally Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma. [PDF]

Cancers (Basel)
Vento J, Zhang T, Kapur P, Hammers H, Brugarolas J, Qin Q.   +5 more
europepmc   +1 more source

Prognostic impact of non-clear cell histology on recurrence and cancer-free survival in renal cell carcinoma: a time-to-event analysis. [PDF]

BMC Urol
Tayeb W, Bakhsh A, Faisal M, Subahi M, Naji H, Badr H, Almohaisen T, Munshi S, Elkoushy MA.   +8 more
europepmc   +1 more source